IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Est. Return 65.21%
This Quarter Est. Return
1 Year Est. Return
+65.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$200M
AUM Growth
-$40.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
142
New
Increased
Reduced
Closed

Top Buys

1
+$16.7M
2
+$13.6M
3
+$9.11M
4
SAGE
Sage Therapeutics
SAGE
+$6.18M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.32M

Top Sells

1
+$12.7M
2
+$11.7M
3
+$11.3M
4
UTHR icon
United Therapeutics
UTHR
+$9.43M
5
CLDX icon
Celldex Therapeutics
CLDX
+$6.2M

Sector Composition

1 Healthcare 98.33%
2 Consumer Staples 0%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$2.93M 0.58%
+23,131
27
$2.93M 0.58%
10,962
+9,840
28
$2.7M 0.54%
+100,000
29
$2.43M 0.48%
162,766
-87,234
30
$1.86M 0.37%
16,809
-8,191
31
$1.72M 0.34%
6,874
-73
32
$1.48M 0.3%
+45,100
33
$1.26M 0.25%
463,156
-372,119
34
$1.19M 0.24%
85,200
-19,800
35
$1.16M 0.23%
+200,000
36
$1.1M 0.22%
+265,000
37
$973K 0.19%
18,954
-37,038
38
$843K 0.17%
6,566
-20,465
39
$839K 0.17%
12,662
-4,233
40
$815K 0.16%
136,059
-517,389
41
$725K 0.14%
288,119
-5,164
42
$612K 0.12%
61,474
-5,552
43
$612K 0.12%
221,830
-140,707
44
$560K 0.11%
2,800
-58,437
45
$558K 0.11%
188,664
-69,189
46
$556K 0.11%
260,087
-62,130
47
$537K 0.11%
448,101
-75,247
48
$521K 0.1%
15,582
-2,978
49
$490K 0.1%
49,031
-108,159
50
$437K 0.09%
156,203
-24,996
1
2
3 4 5